In-hospital mortality and other key outcomes have improved in recent years, but treating these older patients is still associated with certain challenges. 

The drug, which should be available by the end of June, will be marketed under the name Inpefa.

Cardiology came in at No. 3 among all healthcare specialties, trailing only plastic surgery ($619,000) and orthopedics ($573,000).

Kenneth Ellenbogen, MD, detailed some of the biggest trends he saw at the three-day event in New Orleans. 

Researchers used multiple AI models to evaluate EHR data from more than 322,000 heart failure patients. By identifying these subtypes, the group thinks clinicians could perform better risk assessments and make more informed treatment decisions. 

Interventional cardiologists in Detroit developed the new technique with a specific patient in mind. One specialist described it as an "exciting breakthrough."

The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.

Production of Integra’s SurgiMend, PriMatrix, Revize and TissueMend products has been temporarily halted due to the recalls, although the company said it has not received any customer complaints. 

The FDA’s process of reviewing and approving drugs and devices could be put on hold, if lawmakers fail to reach a deal related to the debt ceiling.